An AI research workbench, launched June 30, 2026, that connects Claude to more than 60 scientific databases and computation tools across genomics, proteomics, structural biology and cheminformatics, coordinating specialist sub-agents and a citation/calculation-checking reviewer agent. Built on the ~$400M acqui-hire of ex-Genentech drug-discovery startup Coefficient Bio, it launched alongside an internal Anthropic drug-discovery program targeting diseases traditional biopharma considers commercially unattractive.
Announced next steps from Anthropic that mention Claude Science.
Ongoing 2026
Extend the model lineup and agentic products
Continue the rapid Claude release cadence, having followed Fable 5, Opus 5 and Sonnet 5 with Claude Fable 5.1 and the invitation-only Claude Mythos 5.1 on September 1, 2026, still the latest public models as of September 19, 2026, and deepen enterprise-grade agentic products - including Claude Code (auto mode now default from August 14, 2026), the Claude Cowork 'AI coworker,' the new Claude for Government FedRAMP High beta, and the newly launched Claude Science research workbench and Claude for Financial Services Excel plugin - with stronger admin, analytics and spend controls, plus broader reach through the Claude Partner Network. Reuters reported September 18 that Anthropic is considering a new model to counter OpenAI's GPT-6 Astra, which Ramp put at about 13 percent of tracked enterprise AI spending versus about 8 percent for Claude Fable; Anthropic declined to comment and no name, date or model card has been announced.